This company develops a non-invasive capsule that detects esophageal inflammation, aiding in the diagnosis of gastrointestinal conditions like eosinophilic esophagitis and severe gastroesophageal reflux. The device offers a low-cost alternative to blood tests and radio-imaging for analyzing esophageal content and monitoring treatment effectiveness.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for monitoring esophageal inflammation, such as endoscopy and biopsy, are invasive, costly, and often require sedation, making frequent monitoring challenging for patients with conditions like eosinophilic esophagitis (EoE). This can lead to delayed detection of disease progression or treatment failure.
Solution
EnteroTrack offers the Esophageal String Test (EST) using the EnteroTracker device, a minimally invasive, office-based procedure for collecting mucosal samples from the upper gastrointestinal tract. The Esophageal String Test (EST) enables frequent monitoring of esophageal inflammation without the need for repetitive invasive procedures like endoscopy. The collected samples serve as a liquid biopsy, which can be analyzed by reference laboratories for biomarkers corresponding to disease status, providing precise insights into disease progression and treatment responses. This method offers a more comfortable and cost-effective monitoring approach, improving accessibility, especially in areas lacking affordable endoscopy facilities.
Target Audience
The primary target audience includes gastroenterologists, allergists, and other healthcare professionals who manage patients with eosinophilic esophagitis (EoE) and other upper gastrointestinal disorders, as well as the patients themselves, both adult and pediatric.
Features
- Minimally invasive procedure involving swallowing a capsule attached to a string
- Office-based procedure, eliminating the need for sedation
- Liquid biopsy of mucosal content collected for biomarker analysis
- Monitoring of esophageal inflammation in Eosinophilic Esophagitis (EoE)
- Provides insights into disease progression and treatment responses
- Cost-effective alternative to traditional endoscopy and biopsy
- Samples correlate well with biopsy results, capturing equivalent content and crucial biomarkers